RECURSION PHARMACEUTICALS, INC. (RXRX)
RECURSION PHARMACEUTICALS, INC. (RXRX) has reported earnings 22 times since May 12, 2021. The stock moves an average of ±6.27% the day after reporting, closing higher 36.4% of the time. Its largest post-earnings gain was +12.03% (Aug 09, 2022) and its largest decline was -17.65% (Nov 10, 2021). The next earnings report is predicted for 2026-11-06 (approximate).
Earnings reactions
How RXRX moved on each past earnings report.
Earnings Impact
Total Earnings
22
Avg Abs. Movement
±6.27%
Positive %
36.4%
Negative %
63.6%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Aug 05, 2026 | ☀ PRE | -4.22% | open_in_new |
| May 06, 2026 | ☀ PRE | +1.93% | open_in_new |
| Feb 25, 2026 | ☀ PRE | +6.8% | open_in_new |
| Nov 05, 2025 | ☀ PRE | -0.8% | open_in_new |
Earnings Count
22
Total earnings in dataset
Avg Abs. Movement
±6.27%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 144 | 20260908 | open_in_new SEC.gov |
| 4 | 20260902 | open_in_new SEC.gov |
| 144 | 20260901 | open_in_new SEC.gov |
| 144 | 20260821 | open_in_new SEC.gov |
| 144 | 20260820 | open_in_new SEC.gov |
| 144 | 20260819 | open_in_new SEC.gov |
| 144 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
| 4 | 20260818 | open_in_new SEC.gov |
Frequently asked about RXRX earnings
When does RECURSION PHARMACEUTICALS, INC. report earnings next? expand_more
RECURSION PHARMACEUTICALS, INC. (RXRX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does RXRX stock move after earnings? expand_more
Over 22 reports, RXRX has moved an average of ±6.27% the session after earnings, closing higher 36.4% of the time.
What was RXRX's biggest post-earnings move? expand_more
RXRX's largest post-earnings gain on record was +12.03% on Aug 09, 2022, and its largest decline was -17.65% on Nov 10, 2021.
Where can I find RECURSION PHARMACEUTICALS, INC.'s SEC filings? expand_more
All of RECURSION PHARMACEUTICALS, INC.'s SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right